Buck E. Rogers

6.5k total citations
126 papers, 5.0k citations indexed

About

Buck E. Rogers is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Buck E. Rogers has authored 126 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Radiology, Nuclear Medicine and Imaging, 52 papers in Oncology and 34 papers in Molecular Biology. Recurrent topics in Buck E. Rogers's work include Radiopharmaceutical Chemistry and Applications (58 papers), Monoclonal and Polyclonal Antibodies Research (20 papers) and Virus-based gene therapy research (19 papers). Buck E. Rogers is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (58 papers), Monoclonal and Polyclonal Antibodies Research (20 papers) and Virus-based gene therapy research (19 papers). Buck E. Rogers collaborates with scholars based in United States, Canada and France. Buck E. Rogers's co-authors include David T. Curiel, Kurt R. Zinn, Donald J. Buchsbaum, Carolyn J. Anderson, Jesse J. Parry, Joanne T. Douglas, Rebecca Andrews, Michael J. Welch, Cedric Mpoy and Tandra R. Chaudhuri and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nature Communications.

In The Last Decade

Buck E. Rogers

125 papers receiving 4.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Buck E. Rogers United States	40	2.0k	1.8k	1.7k	1.2k	612	126	5.0k
Byron Hann United States	39	2.5k 1.2×	3.9k 2.1×	696 0.4×	717 0.6×	392 0.6×	83	6.1k
Vladimir Ponomarev United States	35	2.0k 1.0×	1.9k 1.0×	692 0.4×	921 0.8×	300 0.5×	79	4.7k
Alan F. Wahl United States	36	3.3k 1.6×	3.1k 1.7×	2.0k 1.1×	427 0.4×	321 0.5×	64	6.9k
Mian M. Alauddin United States	31	693 0.3×	1.2k 0.6×	1.2k 0.7×	728 0.6×	347 0.6×	109	3.4k
Caius G. Radu United States	44	1.5k 0.7×	3.0k 1.6×	1.8k 1.0×	419 0.3×	315 0.5×	127	6.4k
Donald J. Buchsbaum United States	51	3.4k 1.7×	4.8k 2.6×	1.9k 1.1×	1.5k 1.2×	640 1.0×	281	9.2k
Nancy Hunter United States	46	2.7k 1.3×	2.0k 1.1×	1.2k 0.7×	542 0.4×	291 0.5×	123	6.7k
Steve R. Roffler Taiwan	42	1.3k 0.7×	3.4k 1.8×	975 0.6×	598 0.5×	188 0.3×	168	6.1k
Tony Lahoutte Belgium	50	2.1k 1.0×	3.1k 1.7×	4.5k 2.6×	351 0.3×	260 0.4×	163	7.3k
Silvana Canevari Italy	49	3.2k 1.6×	4.4k 2.4×	1.9k 1.1×	770 0.6×	346 0.6×	227	8.7k

Countries citing papers authored by Buck E. Rogers

Since Specialization

Citations

This map shows the geographic impact of Buck E. Rogers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Buck E. Rogers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Buck E. Rogers more than expected).

Fields of papers citing papers by Buck E. Rogers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Buck E. Rogers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Buck E. Rogers. The network helps show where Buck E. Rogers may publish in the future.

Co-authorship network of co-authors of Buck E. Rogers

This figure shows the co-authorship network connecting the top 25 collaborators of Buck E. Rogers. A scholar is included among the top collaborators of Buck E. Rogers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Buck E. Rogers. Buck E. Rogers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lo, William Chun Yip, Truc T. Huynh, Pamela Samson, et al.. (2024). Using Integrin αvβ6-Targeted Positron Emission Tomography Imaging to Longitudinally Monitor Radiation-Induced Pulmonary Fibrosis In Vivo. International Journal of Radiation Oncology*Biology*Physics. 121(2). 484–492. 1 indexed citations

Singh, Abhay K., Young Ah Goo, Michael L. Nickels, et al.. (2024). Development of a [89Zr]Zr-labeled Human Antibody using a Novel Phage-displayed Human scFv Library. Clinical Cancer Research. 30(7). 1293–1306. 2 indexed citations

Seitzman, Benjamin A., Francisco J. Reynoso, Timothy J. Mitchell, et al.. (2023). Functional network disorganization and cognitive decline following fractionated whole-brain radiation in mice. GeroScience. 46(1). 543–562. 5 indexed citations

Lander, Varintra E., Jad I. Belle, Natalie L. Kingston, et al.. (2022). Stromal Reprogramming by FAK Inhibition Overcomes Radiation Resistance to Allow for Immune Priming and Response to Checkpoint Blockade. Cancer Discovery. 12(12). 2774–2799. 66 indexed citations

Xu, Jinbin, Huaping Chen, Buck E. Rogers, John A. Katzenellenbogen, & Dong Zhou. (2022). Solid phase radiosynthesis of an olaparib derivative using 4-[18F] fluorobenzoic acid and in vivo evaluation in breast and prostate cancer xenograft models for PARP-1 expression. Nuclear Medicine and Biology. 114-115. 65–70. 4 indexed citations

Wang, Yujue, Truc T. Huynh, Nilantha Bandara, et al.. (2021). 2-(4-Hydroxyphenyl)benzothiazole dicarboxylate ester TACN chelators for ⁶⁴ Cu PET imaging in Alzheimer's disease. Dalton Transactions. 51(3). 1216–1224. 10 indexed citations

Lussier, Danielle M., Elise Alspach, Jeffrey P. Ward, et al.. (2021). Radiation-induced neoantigens broaden the immunotherapeutic window of cancers with low mutational loads. Proceedings of the National Academy of Sciences. 118(24). 93 indexed citations

Huynh, Truc T., et al.. (2020). Design of a multivalent bifunctional chelator for diagnostic ⁶⁴ Cu PET imaging in Alzheimer’s disease. Proceedings of the National Academy of Sciences. 117(49). 30928–30933. 28 indexed citations

Huang, Yiran, Nilantha Bandara, Liang Sun, et al.. (2020). Metal-chelating benzothiazole multifunctional compounds for the modulation and ⁶⁴ Cu PET imaging of Aβ aggregation. Chemical Science. 11(30). 7789–7799. 46 indexed citations

10.

Adamo, Luigi, Cibele Rocha‐Resende, Chieh‐Yu Lin, et al.. (2020). Myocardial B cells are a subset of circulating lymphocytes with delayed transit through the heart. JCI Insight. 5(3). 72 indexed citations

11.

Dehdashti, Farrokh, Ningying Wu, Ron Bose, et al.. (2018). Evaluation of [89Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer. Breast Cancer Research and Treatment. 169(3). 523–530. 66 indexed citations

12.

Bandara, Nilantha, Anuj K. Sharma, Stephanie Krieger, et al.. (2017). Evaluation of ⁶⁴Cu-Based Radiopharmaceuticals that Target Aβ Peptide Aggregates as Diagnostic Tools for Alzheimer’s Disease. Journal of the American Chemical Society. 139(36). 12550–12558. 57 indexed citations

13.

Puente, Pilar de la, Nicole Fettig, Micah John Luderer, et al.. (2017). Injectable Hydrogels for Localized Chemotherapy and Radiotherapy in Brain Tumors. Journal of Pharmaceutical Sciences. 107(3). 922–933. 49 indexed citations

14.

Cai, Zhengxin, Qin Ouyang, Dexing Zeng, et al.. (2014). ⁶⁴Cu-Labeled Somatostatin Analogues Conjugated with Cross-Bridged Phosphonate-Based Chelators via Strain-Promoted Click Chemistry for PET Imaging: In silico through in Vivo Studies. Journal of Medicinal Chemistry. 57(14). 6019–6029. 30 indexed citations

15.

Marquez‐Nostra, Bernadette, Oluwatayo Ikotun, Jesse J. Parry, et al.. (2014). Development of a Radiolabeled Irreversible Peptide Ligand for PET Imaging of Vascular Endothelial Growth Factor. Journal of Nuclear Medicine. 55(6). 1029–1034. 7 indexed citations

16.

Nanda, Prasant Kumar, Tammy L. Rold, Gary L. Sieckman, et al.. (2012). Positron-emission tomography (PET) imaging agents for diagnosis of human prostate cancer: agonist vs. antagonist ligands.. PubMed. 26(4). 583–92. 17 indexed citations

17.

Kitamura, Tetsuya, Yayoi Fukuyo, Masahiro Inoue, et al.. (2009). Mutant p53 Disrupts the Stress MAPK Activation Circuit Induced by ASK1-Dependent Stabilization of Daxx. Cancer Research. 69(19). 7681–7688. 18 indexed citations

18.

Rogers, Buck E., Peter L. Roberson, Sui Shen, et al.. (2005). Intraperitoneal Radioimmunotherapy with a Humanized Anti-TAG-72 (CC49) Antibody with a Deleted CH2 Region. Cancer Biotherapy and Radiopharmaceuticals. 20(5). 502–513. 19 indexed citations

19.

Rogers, Buck E., et al.. (2004). In Vitro and In Vivo Evaluation of a ⁶⁴ Cu-Labeled Polyethylene Glycol-Bombesin Conjugate. Cancer Biotherapy and Radiopharmaceuticals. 19(1). 25–34. 46 indexed citations

20.

Roberson, Peter L., Shigeru Yokoyama, Buck E. Rogers, & Donald J. Buchsbaum. (2003). Three-Dimensional Dose Model for the Comparison of ¹⁷⁷ Lu-HuCC49ΔCH2 and ¹⁷⁷ Lu-HuCC49 Radioimunotherapy in Mice Bearing Intraperitoneal Xenografts. Cancer Biotherapy and Radiopharmaceuticals. 18(2). 239–247. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact